The exact mechanism of risk association between T2DM and AD is not clear and several hypotheses were proposed such as altered insulin signaling, impaired glycose and lipid metabolism (metabolic syndrome), and reduced Aβ clearance capacity [142]. The gene discussed is INS; the disease is Alzheimer disease.